Abstract

Pigmentation is the result of melanin synthesis, which takes place in melanocytes, and its further distribution. A dysregulation in melanocytes' functionality can result in the loss of pigmentation, the appearance of pigment spots and melanoma development. Tissue engineering and the screening of new skin-lightening drugs require the development of simple and reproducible in vitro models with maintained functional activity. The aim of the study was to obtain and characterize spheroids from normal human melanocytes as a three-dimensional multicellular structure and as a test system for skin-lightening drug screening. Melanocytes are known to lose their ability to synthesize melanin in monolayer culture. When transferred under non-adhesive conditions in agarose multi-well plates, melanocytes aggregated and formed spheroids. As a result, the amount of melanin elevated almost two times within seven days. MelanoDerm™ (MatTek) skin equivalents were used as a comparison system. Cells in spheroids expressed transcription factors that regulate melanogenesis: MITF and Sox10, the marker of developed melanosomes—gp100, as well as tyrosinase (TYR)—the melanogenesis enzyme and melanocortin receptor 1 (MC1R)—the main receptor regulating melanin synthesis. Expression was maintained during 3D culturing. Thus, it can be stated that spheroids maintain melanocytes' functional activity compared to that in the multi-layered MelanoDerm™ skin equivalents. Culturing both spheroids and MelanoDerm™ for seven days in the presence of the skin-lightening agent fucoxanthin resulted in a more significant lowering of melanin levels in spheroids. Significant down-regulation of gp100, MITF, and Sox10 transcription factors, as well as 10-fold down-regulation of TYR expression, was observed in spheroids by day 7 in the presence of fucoxanthin, thus inhibiting the maturation of melanosomes and the synthesis of melanin. MelanoDerm™ samples were characterized by significant down-regulation of only MITF, Sox10 indicating that spheroids formed a more sensitive system allowed for quantitative assays. Collectively, these data illustrate that normal melanocytes can assemble themselves into spheroids—the viable structures that are able to accumulate melanin and maintain the initial functional activity of melanocytes. These spheroids can be used as a more affordable and easy-to-use test system than commercial skin equivalents for drug screening.

Highlights

  • The pharmaceutical industry is one of the fastest-developing R&D systems

  • 3D cell culture systems have been shown to model that microenvironment in vitro—they allow for maintaining cell morphology, viability, proliferation rate, and differentiation processes, as well as long-term culturing without disturbing the structural integrity (Antoni et al, 2015; Fitzgerald et al, 2015)

  • Cells were characterized by the positive staining against melanocyte-specific marker MEL5, known as a tyrosinase-related protein-1 that is involved in melanin synthesis (Figure 1C)

Read more

Summary

Introduction

The pharmaceutical industry is one of the fastest-developing R&D systems. As long as new products are developed, discovery programs require more accurate and high-throughput in vitro systems for preclinical drug screening and testing. 3D cell culture systems have been shown to model that microenvironment in vitro—they allow for maintaining cell morphology, viability, proliferation rate, and differentiation processes, as well as long-term culturing without disturbing the structural integrity (Antoni et al, 2015; Fitzgerald et al, 2015). Overall, this confirms that 3D cultures are more accurate and valuable in terms of predicting the clinical effects of tested drugs as compared to the 2D culture. In scaffold-based technologies, natural (ECM proteins) or synthetic scaffolds are used to provide mechanical support for cells, as well as to enable them to self-assemble in the preferred manner, similar to the native one (Langhans, 2018)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call